Medical Devices Acquisitions in Kansas

Precision BioLogic Inc., a Halifax-based developer of hemostasis diagnostic products, has acquired George King Bio-Medical, Inc., a provider of fresh frozen human plasmas and hemostasis diagnostic reagents based in Overland Park, Kansas. The acquisition is intended to combine product portfolios and continue serving the bleeding disorders community while exploring new opportunities under the Precision BioLogic umbrella.

Avanos Medical has acquired Nexus Medical, a privately held maker of the TKO anti-reflux needleless connector based in Lenexa, Kansas. The purchase adds Nexus' IV therapy connector technology to Avanos' Specialty Nutrition Systems business to strengthen medication and nutrition delivery in high-acuity settings such as NICUs and PICUs.

Vantage Surgical Solutions, a Pharos Capital Group–backed provider of mobilized ophthalmic surgical equipment and services, acquired Ophthalmic Surgical Solutions (OSS), a Lecompton, Kansas–based ophthalmic equipment and services provider. The deal is an add-on acquisition that expands Vantage’s geographic footprint and clinical capabilities to better serve hospitals and ambulatory surgery centers, particularly in rural communities.

Ampersand-backed Sterling Medical Devices recapitalized and merged with RBC Medical Innovations to create a combined electromechanical medical device design, development and manufacturing company. The transaction brings together complementary capabilities (including energy-based electromechanical device expertise and manufacturing) and appoints industry veteran David Montecalvo as CEO of the combined business.

Agiliti, Inc. (NYSE: AGTI) has agreed to acquire Sizewise Rentals, LLC, a manufacturer and distributor of specialty hospital beds, surfaces and patient handling equipment, in a stock purchase valued at $230 million (approximately 7.7x Adjusted EBITDA). The deal expands Agiliti's equipment solutions capabilities and nationwide service footprint; the transaction was financed with cash and debt (including a $150M incremental Term Loan B) and completed in Q4 2021.